Detalhe da pesquisa
1.
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
Ann Hematol
; 100(6): 1497-1508, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33914097
2.
Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice.
Blood Cancer J
; 11(2): 16, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563899